Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
Case Number:
1:23-cv-00580
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 20, 2024
Vax Patent Battles Heat Up As Attention On Pandemic Wanes
It's been over four years since clinical trials began for COVID-19 vaccines, and while the shots have helped the pandemic recede, the lucrative technology has spurred numerous patent suits, many of which are still in the early stages. Here's a look at some of the key cases in the U.S.
-
May 30, 2023
Alnylam Widens Vaccine IP Litigation Against Pfizer, Moderna
Shortly after obtaining additional patents on vaccine delivery technology from the U.S. Patent and Trademark Office, pharmaceutical company Alnylam has expanded its infringement litigation against Pfizer and Moderna over their COVID-19 vaccines.